Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation

Medical Physics

Volumn 35, Issue 4, 2008, Pages 1571-1579

  Wang, Jianhua ^a   Zhang, Hualin ^b  

^a SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Brachytherapy; Cesium 131; MCNP5; Monte Carlo; Tissue water conversion factor

Indexed keywords

ANISOTROPY; CESIUM; DOSIMETRY; HISTOLOGY; MUSCLE; ONCOLOGY; PHANTOMS; RADIOTHERAPY; RATE CONSTANTS; UROLOGY;

BRACHYTHERAPY; CLINICAL APPLICATION; CLINICAL PRACTICES; CONVERSION FACTOR; DOSE RATE CONSTANTS; DOSIMETRIC PARAMETER; MCNP5; RADIAL DOSE FUNCTION;

MONTE CARLO METHODS;

CESIUM; CESIUM 131; UNCLASSIFIED DRUG; WATER;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; CALCULATION; DOSIMETRY; HUMAN; HUMAN TISSUE; MATHEMATICAL ANALYSIS; MONTE CARLO METHOD; MUSCLE; PARAMETER; PHANTOM; PRIORITY JOURNAL; PROSTATE; SOFT TISSUE; TISSUE WATER;

EID: 41449113191     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2868754     Document Type: Article

References (25)

1. J. F. Williamson, W. Butler, L. A. Dewerd, M. S. Huq, G. S. Ibbott, Z. F. Li, M. G. Mitch, R. Nath, M. J. Rivard, and D. Todor, " Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for P 103 d and I 125 interstitial brachytherapy., " Med. Phys. 0094-2405 10.1118/1.1884925 32, 1424-1439 (2005).
2. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations., " Med. Phys. 0094-2405 10.1118/1.1646040 31, 633-674 (2004).
3. U. K. Henschke and D. C. Lawrence, " Cesium-131 seeds for permanent implants., " Radiology 85, 1117-1119 (1965). 0033-8419
4. M. K. Murphy, R. K. Piper, L. R. Greenwood, M. G. Mitch, P. J. Lamperti, S. M. Seltzer, M. J. Bales, and M. H. Phillips, " Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy., " Med. Phys. 0094-2405 10.1118/1.1755182 31, 1529-1538 (2004).
5. Z. Chen, P. Bongiorni, and R. Nath, " Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry., " Med. Phys. 0094-2405 10.1118/1.2098127 32, 3279-3285 (2005).
6. R. S. Wittman and D. R. Fisher, " Multiple-estimate Monte Carlo calculation of the dose rate constant for a cesium-131 interstitial brachytherapy seed., " Med. Phys. 0094-2405 10.1118/1.2401653 34, 49-54 (2007).
7. M. J. Rivard, " Brachytherapy dosimetry parameters calculated for a C 131 s source., " Med. Phys. 0094-2405 10.1118/1.2432162 34, 754-762 (2007).
8. S. Machtens, R. Baumann, J. Hagemann, A. Warszawski, A. Meyer, J. H. Karstens, and U. Jonas, " Long-term results of interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer., " World J. Urol. 0724-4983 10.1007/s00345-006-0083-1 24, 289-295 (2006).
9. X-5 Monte Carlo Team, MCNP-A General Monte Carlo N -Particle Transport Code, Version 5 (Los Alamos National Laboratory, Los Alamos, NM, 2003).
10. RSICC Computer Code Collection, Monte Carlo N -Particle Transport Code System (Los Alamos National Laboratory, Los Alamos, NM, 2000).
11. J. J. DeMarco, J. B. Smathers, C. M. Burnison, Q. K. Ncube, and T. D. Solberg, " CT-based dosimetry calculations for I 125 prostate implants., " Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 10.1016/S0360-3016(99) 00343-0 45, 1347-1353 (1999).
12. A. S. Meigooni, H. Zhang, J. R. Clark, V. Rachabatthula, and R. A. Koona, " Dosimetric Characteristics of new RadioCoil™ P 103 d wire line source for use in permanent brachytherapy implants., " Med. Phys. 0094-2405 10.1118/1.1809851 31, 3095-3105 (2004).
13. B. Reniers, F. Verhaegen, and S. Vynckier, " The radial dose function of low energy brachytherapy seeds in different solid phantoms: Comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements., " Phys. Med. Biol. 0031-9155 10.1088/0031-9155/49/8/014 49, 1569-1582 (2004).
14. T. D. Bohm, P. M. Deluca, Jr., and L. A. DeWerd, " Brachytherapy dosimetry of I 125 and P 103 d sources using an updated cross section library for the MCNP Monte Carlo transport code., " Med. Phys. 0094-2405 10.1118/1.1562942 30, 701-711 (2003).
15. J. J. DeMarco, R. E. Wallace, and K. Boedecker, " An analysis of MCNP cross sections and tally methods for low energy photon emitters., " Phys. Med. Biol. 0031-9155 10.1088/0031-9155/47/8/307 47, 1321-1332 (2002).
16. H. Zhang, C. Baker, R. McKinsey, and A. S. Meigooni, " Dose verification with Monte Carlo technique for prostate brachytherapy implants with I 125 sources., " Med. Dosim. 30, 85-91 (2005). 0958-3947
17. D. M. Duggan, " Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 brachytherapy sources., " Appl. Radiat. Isot. 0969-8043 10.1016/j.apradiso.2004.05.070 61, 1443-1450 (2004).
18. V. O. Zilio, O. P. Joneja, Y. Popowski, and R. Chawla, " Dosimetric characterization of radioactive sources employed in prostate cancer therapy., " Brachytherapy 1538-4721 10.1016/j.brachy.2004.09.006 3, 201-214 (2004).
19. C. S. Melhus and M. J. Rivard, " Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for C 137 s, I 125, I 192 r, P 103 d, and Y 169 b sources., " Med. Phys. 0094-2405 10.1118/1.2199987 33, 1729-1737 (2006).
20. J. H. Hubble and S. M. Seltzer, " Tables of tables of x-ray mass attenuation coefficients and mass energy-absorption coefficients from 1 keV to 20 MeV for elements Z=1 to 92 and 48 additional substances of dosimetric interest., " NIST IR 5632, 1996.
21. Cross-Section Evaluation Working Group, "ENDF/B-VI summary documentation (ENDF-201)," Brookhaven National Laboratory Report No. BNL-NCS-17541, 8th Ed., National Nuclear Data Center, December 2000.
22. NUDAT 2.0, National nuclear data center, Brookhaven National Laboratory, http://www.nndc.bnl.gov/nudat2/indexjsp (last accessed 10 July 2007).
23. J. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, and R. Nath, " Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources., " Med. Phys. 0094-2405 10.1118/1.598456 25, 2269-2270 (1998).
24. ICRU, "Tissue substitutes in radiation dosimetry and measurement," International Commission on Radiation Units and Measurements, Report No. 44, Bethesda, MD, 1989.
25. A. S. Meigooni, S. B. Awan, N. S. Thompson, and S. A. Dini, " Updated Solid Water™ to water conversion factors for I 125 and P 103 d brachytherapy sources., " Med. Phys. 0094-2405 10.1118/1.2357018 33, 3988-3992 (2006).